These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
122 related articles for article (PubMed ID: 25482341)
1. Theoretical impact on coronary disease of using a computerized clinical decision support system in the prescription of lipid-lowering treatment. Zamora A; Carrion C; Vázquez-Oliva G; Paluzie G; Martín-Urda A; Elosua R Rev Esp Cardiol (Engl Ed); 2015 Jan; 68(1):75-8. PubMed ID: 25482341 [No Abstract] [Full Text] [Related]
2. The Lipoprotein and Coronary Atherosclerosis Study (LCAS) in context: assessing the benefits of lipid-lowering therapy. Introduction. Gotto AM Am J Cardiol; 1998 Sep; 82(6A):1M. PubMed ID: 9766340 [No Abstract] [Full Text] [Related]
3. [Lipid factors and evolution of the atherosclerotic plaque: review of recent trials]. Scardi S G Ital Cardiol; 1996 Dec; 26(12):1481-93. PubMed ID: 9162677 [TBL] [Abstract][Full Text] [Related]
5. Atherosclerosis regression, plaque disruption, and cardiovascular events: a rationale for lipid lowering in coronary artery disease. Brown BG; Zhao XQ; Sacco DE; Albers JJ Annu Rev Med; 1993; 44():365-76. PubMed ID: 8476257 [TBL] [Abstract][Full Text] [Related]
6. Gender differences in achieving optimal lipid goals in patients with coronary artery disease. Victor BM; Teal V; Ahedor L; Karalis DG Am J Cardiol; 2014 May; 113(10):1611-5. PubMed ID: 24698458 [TBL] [Abstract][Full Text] [Related]
7. Use of surrogate endpoints: a practical necessity in lipid-altering and antiatherosclerosis drug development. Orloff DG Am J Cardiol; 2001 Feb; 87(4A):35A-41A. PubMed ID: 11243603 [TBL] [Abstract][Full Text] [Related]
8. The effect of intensive lipid lowering on coronary atheroma and clinical outcome. Houslay ES; Sarma J; Uren NG Heart; 2007 Feb; 93(2):149-51. PubMed ID: 17035507 [TBL] [Abstract][Full Text] [Related]
9. Clinical review 141: lipids and atherosclerosis: lessons learned from randomized controlled trials of lipid lowering and other relevant studies. Kreisberg RA; Oberman A J Clin Endocrinol Metab; 2002 Feb; 87(2):423-37. PubMed ID: 11836262 [No Abstract] [Full Text] [Related]
10. Correlates of repeat lipid testing in patients with coronary heart disease. Virani SS; Woodard LD; Wang D; Chitwood SS; Landrum CR; Urech TH; Pietz K; Chen GJ; Hertz B; Murawsky J; Ballantyne CM; Petersen LA JAMA Intern Med; 2013 Aug; 173(15):1439-44. PubMed ID: 23817669 [TBL] [Abstract][Full Text] [Related]
11. Decrease the incentives to order lipid panels. McConnell M; Downs JR; Good CB JAMA Intern Med; 2014 Mar; 174(3):473. PubMed ID: 24590082 [No Abstract] [Full Text] [Related]
12. Decrease the incentives to order lipid panels--reply. Virani SS; Ballantyne CM; Petersen LA JAMA Intern Med; 2014 Mar; 174(3):473-4. PubMed ID: 24590083 [No Abstract] [Full Text] [Related]
13. Workshop VI--Regression of atherosclerosis: what does it mean? Brown BG Am J Med; 1991 Feb; 90(2A):53S-55S. PubMed ID: 1994718 [No Abstract] [Full Text] [Related]
14. Recent trials of lipid lowering. Ray KK; Cannon CP; Braunwald E Int J Clin Pract; 2007 Jul; 61(7):1145-59. PubMed ID: 17577297 [TBL] [Abstract][Full Text] [Related]
15. Coronary arteriography and lipid lowering: limitations, new concepts, and new paradigms in cardiovascular medicine. Gould KL Am J Cardiol; 1998 Sep; 82(6A):12M-21M. PubMed ID: 9766343 [TBL] [Abstract][Full Text] [Related]
16. [Serum cholesterol during the course of acute coronary events and secondary prevention of coronary heart disease]. Garrido Sanjuán JA; Pía Iglesias G; Sesma Sánchez P An Med Interna; 2001 Sep; 18(9):464-7. PubMed ID: 11715132 [TBL] [Abstract][Full Text] [Related]
17. The problem of overuse. Covinsky KE JAMA Intern Med; 2013 Aug; 173(15):1446. PubMed ID: 23817453 [No Abstract] [Full Text] [Related]